Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Candel Therapeutics Inc
(NQ:
CADL
)
5.170
-0.290 (-5.31%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
517,877
Open
5.440
Bid (Size)
5.100 (30)
Ask (Size)
5.170 (1)
Prev. Close
5.460
Today's Range
5.050 - 5.550
52wk Range
0.6600 - 11.40
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
How Is The Market Feeling About Candel Therapeutics?
Today 12:00 EDT
Via
Benzinga
Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
April 11, 2024
Shares of Fastenal Company (NASDAQ: FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter financial results.
Via
Benzinga
Performance
YTD
+256.55%
+256.55%
1 Month
+244.67%
+244.67%
3 Month
+300.78%
+300.78%
6 Month
+474.38%
+474.38%
1 Year
+316.94%
+316.94%
More News
Read More
12 Health Care Stocks Moving In Thursday's Intraday Session
April 11, 2024
Via
Benzinga
What's Going On With Candel Therapeutics Stock?
April 11, 2024
Via
Benzinga
Exposures
Product Safety
Candel Therapeutics Receives FDA Orphan Drug Designation for CAN-2409 for the Treatment of Pancreatic Cancer
April 11, 2024
From
Candel Therapeutics
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
April 09, 2024
Via
Benzinga
Candel Therapeutics Presents Preclinical Data at AACR on Immunotherapy Candidate for Induction of Tertiary Lymphoid Structures in Solid Tumors
April 09, 2024
From
Candel Therapeutics
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
April 05, 2024
Via
Benzinga
What's Going On With Candel Therapeutics Stock On Friday?
April 05, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
April 05, 2024
Via
Benzinga
Unusually High Volume Points to Upside in These Stocks
April 05, 2024
Via
MarketBeat
Topics
ETFs
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
April 05, 2024
Via
InvestorPlace
Ford, Candel Therapeutics, Nvidia, Palantir, Tesla: Why These 5 Stocks Are On Investors' Radars Today
April 04, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
April 04, 2024
Via
Benzinga
Dow Dips Over 200 Points; RPM International Shares Fall After Q3 Results
April 04, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why STAAR Surgical Shares Are Trading Higher By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
April 04, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
April 04, 2024
Via
Benzinga
Nasdaq Surges 1%; ConAgra Brands Posts Upbeat Earnings
April 04, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
After Brain Cancer Data, Candel Therapeutics' Shares Good News From Pancreatic Cancer Study
April 04, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
April 04, 2024
Via
Benzinga
Candel Therapeutics Announces Positive Interim Data from Randomized Phase 2 Clinical Trial of CAN-2409 in Non-Metastatic Pancreatic Cancer
April 04, 2024
From
Candel Therapeutics
Via
GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
April 04, 2024
Via
InvestorPlace
Micro-Cap Cancer Focused Candel Therapeutics Highlights Encouraging Data From Brain Tumor Immunotherapy
April 01, 2024
Via
Benzinga
Candel Therapeutics Announces Oral Presentation During the 5th Glioblastoma Drug Development Summit with Update on Phase 1b Clinical Trial of CAN-3110 in Recurrent High-Grade Glioma
March 28, 2024
From
Candel Therapeutics
Via
GlobeNewswire
CADL Stock Earnings: Candel Therapeutics Misses EPS for Q4 2023
March 28, 2024
Via
InvestorPlace
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.